UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL

NCT04544592 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

45

Enrollment

OTHER

Sponsor class

Conditions

B-cell Acute Lymphoblastic Leukemia
B-cell Non Hodgkin Lymphoma

Interventions

DRUG: CD19CAR-CD3Zeta-4-1BB-Expressing Autologous T-Lymphocyte Cells

Sponsor

University of Colorado, Denver

Collaborators

[object Object]